About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
CRIPS is a research group focusing on severe acute respiratory infections and sepsis.
The objective is to develop projects on clinical and translational research in hospital-acquired pneumonia, community-acquired pneumonia, and severe viral respiratory infections, such as influenza and COVID-19. CRIPS also develop epidemiological studies focused on risk and prognostic factors for multi-resistant pathogens, validation of ventilator-associated events in ventilated adult and pediatric patients, incorporating artificial intelligence techniques. It also highlights evidence-based medicine (EBM) research, evaluating therapies and prevention strategies and participating in the formulation of clinical practice guidelines, as part of CIBERES and the European Society for Clinical Microbiology and Infections. The EBM research focuses on knowledge translation to get research findings to the point of decision making, providing health-related recommendations, focusing on clinical research and relevance of care.
CRIPS collaborate on a Local (UIC, IDIAP), National (CIBERES), and International level (CHU Nimes, Uolo University, ISARIC and Pneumo-Inspire Networks).
PMID: 32311297 Journal: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Year: 2020 Reference: Am J Respir Crit Care Med. 2020 Jun 1;201(11):1324-1325. doi: 10.1164/rccm.202004-1153ED. Impact factor: 17.452 Publication type: Editorail in international publication Authors: Waterer, Grant W, Rello, Jordi, Wunderink, Richard G et al. DOI: 10.1164/rccm.202004-1153ED
PMID: 31272810 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2020 Reference: Enferm Infecc Microbiol Clin. 2020 Mar;38(3):111-118. doi: 10.1016/j.eimc.2019.05.005. Epub 2019 Jul 1. Impact factor: 1.654 Publication type: Paper in national publication Authors: Garcia-Moreno, Jorge, Melendo-Perez, Susana, Martin-Gomez, Maria Teresa, Frick, Marie Antoinette, Balcells-Ramirez, Joan, Pujol-Jover, Montserrat, Martin-Nalda, Andrea, Mendoza-Palomar, Natalia, Soler-Palacin, Pere et al. DOI: 10.1016/j.eimc.2019.05.005
PMID: 32278670 Journal: Anaesthesia Critical Care & Pain Medicine Year: 2020 Reference: Anaesth Crit Care Pain Med. 2020 Oct;39(5):553-561. doi: 10.1016/j.accpm.2020.04.001. Epub 2020 Apr 9. Impact factor: 2.707 Publication type: Paper in international publication Authors: Barrasa, Helena, Rello, Jordi, Tejada, Sofia, Martin, Alejandro, Balziskueta, Goiatz, Vinuesa, Cristina, Fernandez-Miret, Borja, Villagra, Ana, Vallejo, Ana, Sebastian, Ana San et al. DOI: 10.1016/j.accpm.2020.04.001
PMID: 32245452 Journal: BMC Pulmonary Medicine Year: 2020 Reference: BMC Pulm Med. 2020 Apr 3;20(1):83. doi: 10.1186/s12890-020-1115-0. Impact factor: 2.813 Publication type: Paper in international publication Authors: Monso, Eduard, Angrill, Nuria, Gallego, Miguel, Font, Juli, Valles, Jordi, Moron, Anisi, Rello, Jordi et al. DOI: 10.1186/s12890-020-1115-0
PMID: 21248638 Journal: CURRENT OPINION IN GASTROENTEROLOGY Year: 2011 Reference: Curr Opin Gastroenterol. 2011 Mar;27(2):160-6. Impact factor: 4.107 Publication type: Paper in international publication Authors: , , et al. DOI: 10.1097/MOG.0b013e32834373b1
PMID: 21144985 Journal: CRITICAL CARE CLINICS Year: 2011 Reference: Crit Care Clin. 2011 Jan;27(1):35-51. Impact factor: 2.284 Publication type: Paper in international publication Authors: Ulldemolins, Marta, Nuvials, Xavier, Palomar, Mercedes, Masclans, Joan R, Rello, Jordi et al. DOI: 10.1016/j.ccc.2010.09.007
A study, in which Vall d'Hebron has participated, has analysed all the interventions of this type carried out between 2006 and 2020.
The work of the multinational team, which has reviewed the records of more than one million patients who have received a new organ, has found significant differences between women and men
The scientific review reports that changes in the respiratory system flora due to pollution increase the risk of suffering a hospital infection caused by multidrug-resistant organisms.
